Introduction: Parathyroid hormone-related protein (PTHrP) is widely expressed in the fibrous layer of the periosteum (PO) on cortical bone surfaces. PO, the membrane lining the outside of cortical bone, is an important player during both modeling and remodeling. The PO is composed of an outer fibrous layer, where PTHrP is expressed, and an inner cambial layer, where PTHR1 is expressed; the cambial layer gives rise to the PO osteoblasts (OBs) and osteoclasts (OCs) that model/remodel the cortical bone surface, especially during fracture healing (Fig. A) . Biologically, cortical bone modeling is critical for the structural and functional integrity of the musculoskeletal system. Cortical bone modeling accounts for the mechanical molding of bone. Without PO-driven cortical bone modeling, bones cannot grow properly. For example, they will not change their overall shape corresponding to physiologic influences or mechanical forces. Furthermore, PO is critical for fracture and bone graft healing, as well as tissue engineering. We propose that PTHrP in the fibrous layer of the PO is a key regulatory factor in remodeling bone formation during fracture repair. Recent studies in our lab revealed that PTHrP expressed in the fibrous PO regulated bone formation in the subjacent cambial layer, thereby modeling the cortical bone surface. These data constitute the first genetic evidence for such PTHrP regulatory effects and are the scientific basis of this abstract. We tested here the hypothesis that PTHrP in the fibrous PO induces OBs in the subjacent cambial PO by a tibial fracture model using CD1 control and PTHrP conditional knockout (cKO) mice. We generated PTHrP cKO mice by conditionally deleting it using scleraxis targeting (Scx-Cre); Scx is a bHLH transcription factor that is expressed in the fascia and connective tissue that binds bones and muscle together and to each other. Methods: To determine whether the Scx-Cre transgene could target floxed genes specifically in PO in vivo, Scx-Cre transgenic mice were bred with Rosa26 reporter mice. Cre-recombination efficiency was evaluated by X-gal staining. X-gal staining was also performed in PThrP-lacZ (PTHrPlacZ/+) mice to confirm PTHrP was expressed at PO. The loss of function PTHrP (Scx-Cre;PTHrPlacZfllx) mouse model was produced by breeding Scx-Cre mice with mice bearing one null PTHrP allele replaced by lacZ sequences and one floxed PTHrP allele. The tibial fracture procedure was performed on the right hind limbs of 10-week-old CD1 and PTHrP cKO mice as follows: 1) a 5mm incision was made in the skin on the anterior tibia using a scalpel; 2) a 25 gauge needle was inserted into the tibia marrow cavity through the medial side of the tibial plateau; 3) the needle was removed and the midsection of the tibia was transected with a scalpel; 4) the needle was reinserted and the extra needle outside the tibia was cut; 5) the wound was closed with 4.0 nylon sutures; 6) X-ray imaging was performed to confirm needle placement and transection fracture. The left control tibia was only exposed by incision and sutured without manipulating the tibia. All mice were handled according to USDA guidelines and with the approval of the Yale Animal Care and Use Committee. To determine whether the PTHrP gene could be turned on during fracture healing, we also performed tibial fracture in PThrPlacZ mice. Both left and right mouse tibia samples were harvested 3, 7, and 14 days post fracture surgery (n=3/group). X-Gal staining was performed to evaluate PTHrP expression after fracture. Both left and right CD1 and PTHrP cKO mouse tibia samples were harvested 3, 7, and 14 days post fracture surgery (n=3/group). X-ray images were taken before sacrificing the mice. For histology, samples were embedded in paraffin and analyzed in sagittal sections. Toluidine blue (TB) staining was performed to characterize the basic histological change in each time point. Alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP) staining were performed to assess changes in OB and OC activities in these mice. Callus size, OB, and OC area at each time point were quantified by ImagePro4.5. Results: High-level Cre recombination was seen in Scx-Cre;R26R mice. Moreover, histological specimens of X-gal-stained samples in Scx-Cre;R26R and PTHrP-lacZ mice showed a 100% correspondence of PTHrP and Scx-Cre expression at PO. As expected, X-gal staining in PTHrP-lacZ mice revealed that PTHrP gene was turned on in PO within 3 days post-facture indicating that PO PTHrP plays a role during fracture healing. Overall, the fracture healing in cKO mice was delayed compared to CD1 mice. Radiograph data showed that both CD1 and cKO tibia samples had no morphological change (i.e., no callus formation) 3 days post-fracture. By 7 days post-fracture, both CD1 and cKO mice had formed a callus at the fracture site. However, the callus size in cKO mice was 70% smaller compared to CD1 mice. At 14 days post-fracture, CD1 callus size was 5% larger than day 7 while cKO callus size was 50% larger than day 7. However, cKO callus size remained 20% smaller than CD1 mice. Toluidine blue staining revealed more details: Despite the difference in PTHrP expression, there was no histological difference in CD1 and cKO mice 3 days post-fracture. However, by 7 days post-fracture, cells in the callus of CD1 mice were composed of periosteal MSCs, chondrocytes, and some woven bone whereas in cKO mice, there were much fewer chondrocytes and soft callus. By day 14, the fracture sites in CD1 mice were largely composed of mineralized bone while the fracture sites in cKO mice were mainly composed of soft callus with less new bone formation (Figs. B, C) .
To further understand the remodeling process in fracture healing, we performed ALP (an indicator for OB activity) and TRAP staining (an indicator of OC activity). Overall, there were less ALP and TRAP in cKO mice compared to CD1 mice. There was 60% less ALP positive staining in cKO mice compared to CD1 mice 7 days post-fracture, and about 50% less ALP staining in cKO mice compared to CD1 mice 14 days post-fracture. However, the ALP positive area was 4 times greater in CD1 mice 14 days postfracture compared to 7-day CD1 mice, and was about 7 times greater in cKO mice 14 days post-fracture compared to 7-day cKO mice. Our results revealed that there was 68% less TRAP positive staining in cKO mice compared to CD1 mice 7 days postfracture, and about 45% less TRAP staining in cKO mice compared to CD1 mice 14 days post-fracture. Moreover, the TRAP positive area was 17 times greater in CD1 mice 14 days post-fracture compared to 7-day CD1 mice, and was about 29 times greater in cKO mice 14 days post-fracture compared to 7-day cKO mice. Discussion: During fracture healing, a key event is that the periosteal progenitor cells respond to the trauma and enter the osteogenic and chondrogenic stage. Thus, PO is critical for fracture healing. It is also known that PTHrP is critical during bone formation and PTHrP is expressed in PO. However, the role of PTHrP in PO has not been studied. Our data indicate that deletion of PTHrP in PO delays the healing process during fracture. Our results provide the initial insight and evidence that PO PTHrP is an important regulator during fracture repair. Further study will provide insight into the mechanism of PTHrP regulation of cortical bone remodeling during fracture healing. Significance: The regulation of PO membranous bone remodeling during fracture is poorly understood but biologically and clinically important. Our data portray PO PTHrP as an appealing candidate to accelerate fracture healing. Acknowledgments: References:
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